[go: up one dir, main page]

DE69906974D1 - Thixotrope formulierungen zur befüllung von gelatinekapseln - Google Patents

Thixotrope formulierungen zur befüllung von gelatinekapseln

Info

Publication number
DE69906974D1
DE69906974D1 DE69906974T DE69906974T DE69906974D1 DE 69906974 D1 DE69906974 D1 DE 69906974D1 DE 69906974 T DE69906974 T DE 69906974T DE 69906974 T DE69906974 T DE 69906974T DE 69906974 D1 DE69906974 D1 DE 69906974D1
Authority
DE
Germany
Prior art keywords
filling
compositions
thixotrope
formulations
consistency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69906974T
Other languages
English (en)
Other versions
DE69906974T2 (de
Inventor
Pascal Lombardin
Jean-Louis Grossiord
Monique Seiller
Elie Leverd
Eric Goutay
Jo L Bougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE69906974D1 publication Critical patent/DE69906974D1/de
Publication of DE69906974T2 publication Critical patent/DE69906974T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69906974T 1998-07-07 1999-07-05 Thixotrope formulierungen zur befüllung von gelatinekapseln Expired - Fee Related DE69906974T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808664 1998-07-07
FR9808664A FR2781373B1 (fr) 1998-07-07 1998-07-07 Formulations thixotropes pour le remplissage de gelules
PCT/FR1999/001614 WO2000001371A1 (fr) 1998-07-07 1999-07-05 Formulations thixotropes pour le remplissage de gelules

Publications (2)

Publication Number Publication Date
DE69906974D1 true DE69906974D1 (de) 2003-05-22
DE69906974T2 DE69906974T2 (de) 2004-02-26

Family

ID=9528339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906974T Expired - Fee Related DE69906974T2 (de) 1998-07-07 1999-07-05 Thixotrope formulierungen zur befüllung von gelatinekapseln

Country Status (15)

Country Link
US (1) US6709675B1 (de)
EP (1) EP1094791B1 (de)
JP (1) JP2002519370A (de)
CN (1) CN1211124C (de)
AT (1) ATE237318T1 (de)
AU (1) AU760665B2 (de)
BR (1) BR9911905A (de)
CA (1) CA2337273A1 (de)
DE (1) DE69906974T2 (de)
DK (1) DK1094791T3 (de)
ES (1) ES2197647T3 (de)
FR (1) FR2781373B1 (de)
PT (1) PT1094791E (de)
WO (1) WO2000001371A1 (de)
ZA (1) ZA200100052B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4105091B2 (ja) * 2001-09-10 2008-06-18 エフ．ホフマン−ラ ロシュ アーゲー 油性チキソトロープ性配合物
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
WO2005000279A1 (ja) * 2003-06-27 2005-01-06 Wakunaga Pharmaceutical Co., Ltd. 硬カプセル剤
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US8318210B2 (en) * 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
US8309128B2 (en) 2005-06-10 2012-11-13 Pierre Fabre Medicament Stabilized milnacipran formulation
CN100335135C (zh) * 2005-11-04 2007-09-05 天津太平洋制药有限公司 银杏叶提取物胶囊组合物及其制备方法
US20080319083A1 (en) * 2006-01-27 2008-12-25 Asahi Kasei Pharma Corporation Medicine for transnasal administration
US9157063B2 (en) * 2007-01-16 2015-10-13 Texas Tech University System Method and apparatus for gender selection based on pH
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
JO3587B1 (ar) * 2010-06-02 2020-07-05 Astellas Deutschland Gmbh أشكال جرعات بينداموستين عن طريق الفم
US8978783B2 (en) 2011-05-26 2015-03-17 Smith International, Inc. Jet arrangement on an expandable downhole tool
US20160331695A1 (en) * 2014-01-31 2016-11-17 Fuji Capsule Co., Ltd. Capsule Formulation
DE102016109669A1 (de) 2016-05-25 2017-11-30 Tiernahrung Deuerer Gmbh Verfahren zum Herstellen eines Tiernahrungsproduktes
JP2021500318A (ja) 2017-10-19 2021-01-07 サインパス ファルマ, インク.Signpath Pharma, Inc. チャネル病を引き起こす薬物に対するｄｍｐｃ、ｄｍｐｇ、ｄｍｐｃ／ｄｍｐｇ、ｌｙｓｏｐｇ及びｌｙｓｏｐｃの防御効果

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
DK0461290T3 (da) * 1990-06-14 1994-02-21 Henning Berlin Gmbh Væskefyldte stikkapsler
EP0517412A1 (de) * 1991-06-03 1992-12-09 MERCK SHARP & DOHME LTD. Pharmazeutische Zusammensetzungen enthaltend eine Benzodiazepen
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
JPH11507667A (ja) * 1995-06-09 1999-07-06 アール ピー シーラー コーポレーション 粒状物質を含有する軟ゼラチンカプセル
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
ZA9710927B (en) * 1996-12-06 1998-06-15 Fujisawa Pharmaceutical Co Pharmaceutical composition.
FR2761265B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6365181B1 (en) * 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition

Also Published As

Publication number Publication date
CN1308522A (zh) 2001-08-15
JP2002519370A (ja) 2002-07-02
DK1094791T3 (da) 2003-08-11
WO2000001371A1 (fr) 2000-01-13
PT1094791E (pt) 2003-08-29
DE69906974T2 (de) 2004-02-26
FR2781373B1 (fr) 2001-09-21
ES2197647T3 (es) 2004-01-01
EP1094791A1 (de) 2001-05-02
AU4622799A (en) 2000-01-24
US6709675B1 (en) 2004-03-23
BR9911905A (pt) 2001-03-27
FR2781373A1 (fr) 2000-01-28
CA2337273A1 (fr) 2000-01-13
CN1211124C (zh) 2005-07-20
ZA200100052B (en) 2001-07-16
ATE237318T1 (de) 2003-05-15
AU760665B2 (en) 2003-05-22
EP1094791B1 (de) 2003-04-16

Similar Documents

Publication Publication Date Title
DE69906974D1 (de) Thixotrope formulierungen zur befüllung von gelatinekapseln
ATE429210T1 (de) Orale flüssige zusammensetzungen
ATE235235T1 (de) Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
GT200800037A (es) Solucion de cloruro de sodio para reconstitucion o dilucion de farmacos
CA2382540A1 (en) High viscosity liquid composition for the delivery of substances
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
GT199900069A (es) Preparaciones farmaceuticas estabilizadas de gabapentina y proceso para prepararla.
DK1993515T3 (da) Fremgangsmåde til solubilisering, dispergering og stabilisering af stoffer, produkter, der er fremstillet efter fremgangsmåden og anvendelsen af samme
ID26221A (id) Komposisi-komposisi farmasi yang dapat dijadikan gel
CR8766A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
Singh et al. Formulation development & evaluation of topical gel formulations using different gelling agents and its comparison with marketed gel formulation
EA200702320A1 (ru) Соединения trpv1 агониста и способы их получения и применения
MY209656A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability
DK1267833T3 (da) Farmaceutiske præparater og fremgangsmåde til fremstilling deraf
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
EP3354283A3 (de) Pharmazeutische kapselzusammensetzung mit silodosin
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
DK1474491T3 (da) Anvendelse af antiadhæsive emballagematerialer til emballering af kemikalier og levnedsmidler
ES2133918T3 (es) Nuevos esteroides seco-d activos en el sistema cardiovascular y composiciones farmaceuticas que los contienen.
MXPA05010254A (es) Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma.
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
WO2020053658A3 (en) Non-aqueous chemotherapeutic solutions for oral dosage

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee